세계의 헬스케어 나노테크놀러지 시장 보고서(2025년)

Healthcare Nanotechnology Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

헬스케어 나노기술 시장 규모는 향후 몇 년동안 급성장할 것으로 예상되며, 2029년에는 16.8%의 성장률로 7,231억 8,000만 달러에 달할 것으로 전망됩니다. 예측 기간의 성장은 셀라노스틱스 개발, 유전자 치료용 나노입자, 생체적합성 나노물질, 나노 대응 수술기구, 나노 스케일 치료제, 세계 보건 비상사태 대비 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 진단용 나노기기, 바이오센서 및 영상, 나노로봇 및 나노수술, 개인맞춤형 의료, 일반인 인식 및 교육 치료 적용 등이 있습니다.

암 발병률 증가는 헬스케어 나노기술 시장의 성장을 견인할 것으로 예상됩니다. 나노기술은 암 치료에 대한 유망한 접근 방식이며, 암을 포함한 다양한 질병에 대해 보다 개인화된 치료 가능성을 제공합니다. 암의 세계 유병률은 계속 증가하고 있습니다. 예를 들어, 미국암협회는 2023년 미국에서 195만 8,310명이 새로 암 진단을 받고 60만 9,820명이 암으로 사망할 것으로 추정하고 있습니다. 이러한 통계는 의료기술과 조기 발견법의 발전에도 불구하고 암의 예방과 치료의 어려움이 여전하다는 것을 강조합니다. 이러한 통계는 암에 효과적으로 대처하기 위한 지속적인 연구와 효과적인 헬스케어 전략의 시급한 필요성을 강조하고 있습니다. 결과적으로, 암 환자 수 증가는 헬스케어 나노기술 시장의 성장에 박차를 가하고 있습니다.

당뇨병과 비만 증가는 향후 헬스케어 나노기술 시장의 성장을 가속할 것으로 예상됩니다. 당뇨병은 혈당 수치가 너무 높을 때 발병하는 상태를 말하며, 비만은 BMI가 30 이상인 상태를 말합니다. 헬스케어 나노기술은 당뇨병과 비만을 관리하기 위한 표적 약물 전달과 정밀의료 접근법을 제공하여 부작용을 최소화하면서 치료 효과를 향상시킵니다. 예를 들어, 벨기에에 본부를 둔 국제당뇨병연맹(International Diabetes Federation)에 따르면, 2022년 6월 세계 당뇨병 유병률은 10.5%로 증가할 것이며, 그 중 절반 이상(44.7%)이 미진단 상태로 남아있을 것으로 보고되고 있습니다. 예측에 따르면, 2045년까지 7억 8,300만 명의 성인, 즉 8명 중 1명이 당뇨병을 앓게 될 것으로 예상하고 있습니다. 이는 같은 기간 예상 인구 증가율(20%)의 두 배 이상인 46% 증가를 의미합니다. 또한, 2022년 3월, 스위스에 본부를 둔 세계보건기구(WHO)는 2025년까지 성인 6억 5,000만 명, 청소년 3억 4,000만 명, 어린이 3,900만 명이 비만이 될 것으로 예상하고 있습니다. 과체중 또는 비만이 될 것으로 예측했습니다. 따라서 당뇨병과 비만 증가는 헬스케어 나노기술 시장의 성장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장-금리, 인플레이션, 지정학, 코로나재난, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 헬스케어 나노테크놀러지 시장 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업 분석
• 세계의 헬스케어 나노테크놀러지 시장 성장률 분석
• 세계의 헬스케어 나노테크놀러지 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 헬스케어 나노테크놀러지 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 헬스케어 나노테크놀러지 유효 시장(TAM)

제6장 시장 세분화

• 세계의 헬스케어 나노테크놀러지 시장 : 질환별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 심혈관 질환
• 종양성 질환
• 신경 질환
• 정형외과 질환
• 감염증
• 세계의 헬스케어 나노테크놀러지 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 유기
• 무기
• 탄소 기반
• 세계의 헬스케어 나노테크놀러지 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 약물전달
• 생체 재료
• 액티브 임플란트
• 조직 재생
• 세계의 헬스케어 나노테크놀러지 시장 : 심혈관질환 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 약물전달 시스템
• 영상 진단
• 세계의 헬스케어 나노테크놀러지 시장 : 종양성 질환 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 표적 약물전달
• 나노입자 기반 치료법
• 영상 진단
• 세계의 헬스케어 나노테크놀러지 시장 : 신경질환 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 나노입자 기반 약물전달
• 진단 툴
• 세계의 헬스케어 나노테크놀러지 시장 : 정형외과 질환 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 뼈 재생 및 수복
• 약물전달 시스템
• 세계의 헬스케어 나노테크놀러지 시장 : 감염증 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 항균 나노재료
• 백신 전달 시스템

제7장 지역별/국가별 분석

• 세계의 헬스케어 나노테크놀러지 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 헬스케어 나노테크놀러지 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 헬스케어 나노테크놀러지 시장 : 경쟁 구도
• 헬스케어 나노테크놀러지 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Teva Pharmaceutical Industries Ltd.
• Sanofi SA
• Taiwan Liposome Company Ltd.
• GE Healthcare Technologies Inc.
• Mallinckrodt plc
• Leadiant Biosciences
• Luminex Corporation
• Bristol-Myers Squibb Company
• CytImmune Sciences Inc.
• Nanobiotix
• Starpharma Holdings Limited
• Copernicus Therapeutics Inc.
• NanoCarrier Co. Ltd
• LiPlasome Pharma ApS
• Nami Therapeutics Corp.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 시장 최근 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 헬스케어 나노테크놀러지 시장(2029년) - 가장 새로운 기회를 제공하는 국가
• 헬스케어 나노테크놀러지 시장(2029년) - 가장 새로운 기회를 제공하는 부문
• 헬스케어 나노테크놀러지 시장(2029년) - 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration.

The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $344.23 billion in 2024 to $389.11 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $723.18 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and education therapeutic applications.

The rising incidence of cancer cases is anticipated to drive the growth of the healthcare nanotechnology market. Nanotechnology represents a promising approach to cancer treatment, offering the potential for more personalized therapies for various diseases, including cancer. The global prevalence of cancer continues to rise. For example, in 2023, the American Cancer Society estimated that there would be 1,958,310 new cancer diagnoses and 609,820 cancer-related deaths in the United States. These statistics underscore the persistent challenges in cancer prevention and treatment, despite advancements in medical technology and early detection methods. They highlight the urgent need for ongoing research and effective healthcare strategies to address cancer effectively. Consequently, the increasing number of cancer cases is fueling the growth of the healthcare nanotechnology market.

Growing incidences of diabetes and obesity are expected to propel the growth of the healthcare nanotechnology market going forward. Diabetes refers to a condition that develops when blood glucose levels are too high, and obesity refers to the condition of having a body mass index of 30 or more. Healthcare nanotechnology offers targeted drug delivery and precision medicine approaches to manage diabetes and obesity, improving treatment efficacy while minimizing side effects. For instance, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10. 5% worldwide, with over half (44. 7%) of people still undiagnosed. According to IDF predictions, 783 million adults, or one in eight people, will have diabetes by 2045. This would represent a 46% rise, more than double the projected population growth for the same period (20%). Furthermore, in March 2022, according to the World Health Organization, a Switzerland-based agency, 650 million adults, 340 million teenagers, and 39 million children will be obese. This quantity is still rising, and the WHO predicts that by 2025, 167 million adults and children will become overweight or obese. Therefore, growing incidences of diabetes and obesity are driving the growth of the healthcare nanotechnology market.

Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. In January 2022, NaNotics, a US-based medical company, collaborated with the Mayo Clinic to develop a cancer treatment known as NaNots. The collaboration will involve NaNotics sharing its nano-depletion platform with Mayo researchers, while the Mayo Clinic will provide its own PD-L1 antibody and a transgenic mouse model that provides human sPD-L1. Mayo Clinic is a US-based clinic dedicated to providing patient care, education, and research in various fields of medicine, including nanomedicine.

Major companies operating in the healthcare nanotechnology market are increasing their focus on introducing nanotechnology-based gel serums to gain a competitive edge in the market. Nanotechnology-based gel serums are products that incorporate nanoscale particles or delivery systems to enhance the absorption and effectiveness of active ingredients. For instance, in March 2023, ENTOD Pharmaceuticals, an India-based healthcare company, launched Eyecirque, a nanotechnology-based under-eye product, in India. Eyecirque is formulated with a cutting-edge, 100% plant-based biocellular composition, featuring vitamin A, C, and E complexes, anti-aging antioxidants, skin-brightening agents, and naturally occurring ultra-moisturizing elements that are rapidly absorbed into the skin around the eyes at a nano-molecular level. It stands as the world's first gel serum of its kind, utilizing nanotechnology to address concerns such as wrinkles, hollowness, hollow eyelids, and dark circles under the eyes.

In January 2024, GenEdit, Inc., a US-based biotechnology firm, announced a multiyear collaboration and licensing agreement with Genentech to develop innovative nanoparticles for the delivery of genetic medicines intended to treat autoimmune diseases. This partnership will utilize GenEdit's NanoGalaxy platform, emphasizing the discovery of hydrophilic nanoparticles (HNPs) for nucleic acid-based therapies. Genentech, also based in the US, is a biotechnology corporation that specializes in healthcare nanotechnology.

Major companies operating in the healthcare nanotechnology market include Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanoviricides Inc., Nanosys Inc., Nanocarrier Co. Ltd., Nanocyl SA, Nanogen Pvt. Ltd.

North America was the largest region in the healthcare nanotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the healthcare nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Nanotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare nanotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The healthcare nanotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease: Cardiovascular Diseases; Oncological Diseases; Neurological Diseases; Orthopedic Diseases; Infectious Diseases
• 2) By Type: Organic; Inorganic; Carbon-Based
• 3) By Application: Drug Delivery; Biomaterials; Active Implants; Tissue Regeneration
• Subsegments:
• 1) By Cardiovascular Diseases: Drug Delivery Systems; Diagnostic Imaging
• 2) By Oncological Diseases: Targeted Drug delivery; Nanoparticle-Based Therapies; Imaging And Diagnostics
• 3) By Neurological Diseases: Nanoparticle-Based Drug Delivery; Diagnostic Tools
• 4) By Orthopedic Diseases: Bone regeneration And Repair; Drug Delivery Systems
• 5) By Infectious Diseases: Antimicrobial Nanomaterials; Vaccine Delivery Systems
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Merck & Company Inc.; Union Chimique Belge S. A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Healthcare Nanotechnology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Healthcare Nanotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Healthcare Nanotechnology Market Growth Rate Analysis
• 5.4. Global Healthcare Nanotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Healthcare Nanotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Healthcare Nanotechnology Total Addressable Market (TAM)

6. Healthcare Nanotechnology Market Segmentation

• 6.1. Global Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Oncological Diseases
• Neurological Diseases
• Orthopedic Diseases
• Infectious Diseases
• 6.2. Global Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Organic
• Inorganic
• Carbon-Based
• 6.3. Global Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Delivery
• Biomaterials
• Active Implants
• Tissue Regeneration
• 6.4. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Cardiovascular Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Delivery Systems
• Diagnostic Imaging
• 6.5. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Oncological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Drug delivery
• Nanoparticle-Based Therapies
• Imaging And Diagnostics
• 6.6. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Neurological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoparticle-Based Drug Delivery
• Diagnostic Tools
• 6.7. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Orthopedic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone regeneration And Repair
• Drug Delivery Systems
• 6.8. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Infectious Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimicrobial Nanomaterials
• Vaccine Delivery Systems

7. Healthcare Nanotechnology Market Regional And Country Analysis

• 7.1. Global Healthcare Nanotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Healthcare Nanotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Healthcare Nanotechnology Market

• 8.1. Asia-Pacific Healthcare Nanotechnology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Healthcare Nanotechnology Market

• 9.1. China Healthcare Nanotechnology Market Overview
• 9.2. China Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Healthcare Nanotechnology Market

• 10.1. India Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Healthcare Nanotechnology Market

• 11.1. Japan Healthcare Nanotechnology Market Overview
• 11.2. Japan Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Healthcare Nanotechnology Market

• 12.1. Australia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Healthcare Nanotechnology Market

• 13.1. Indonesia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Healthcare Nanotechnology Market

• 14.1. South Korea Healthcare Nanotechnology Market Overview
• 14.2. South Korea Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Healthcare Nanotechnology Market

• 15.1. Western Europe Healthcare Nanotechnology Market Overview
• 15.2. Western Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Healthcare Nanotechnology Market

• 16.1. UK Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Healthcare Nanotechnology Market

• 17.1. Germany Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Healthcare Nanotechnology Market

• 18.1. France Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Healthcare Nanotechnology Market

• 19.1. Italy Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Healthcare Nanotechnology Market

• 20.1. Spain Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Healthcare Nanotechnology Market

• 21.1. Eastern Europe Healthcare Nanotechnology Market Overview
• 21.2. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Healthcare Nanotechnology Market

• 22.1. Russia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Healthcare Nanotechnology Market

• 23.1. North America Healthcare Nanotechnology Market Overview
• 23.2. North America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Healthcare Nanotechnology Market

• 24.1. USA Healthcare Nanotechnology Market Overview
• 24.2. USA Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Healthcare Nanotechnology Market

• 25.1. Canada Healthcare Nanotechnology Market Overview
• 25.2. Canada Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Healthcare Nanotechnology Market

• 26.1. South America Healthcare Nanotechnology Market Overview
• 26.2. South America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Healthcare Nanotechnology Market

• 27.1. Brazil Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Healthcare Nanotechnology Market

• 28.1. Middle East Healthcare Nanotechnology Market Overview
• 28.2. Middle East Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Healthcare Nanotechnology Market

• 29.1. Africa Healthcare Nanotechnology Market Overview
• 29.2. Africa Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

• 30.1. Healthcare Nanotechnology Market Competitive Landscape
• 30.2. Healthcare Nanotechnology Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

31. Healthcare Nanotechnology Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Sanofi SA
• 31.3. Taiwan Liposome Company Ltd.
• 31.4. GE Healthcare Technologies Inc.
• 31.5. Mallinckrodt plc
• 31.6. Leadiant Biosciences
• 31.7. Luminex Corporation
• 31.8. Bristol-Myers Squibb Company
• 31.9. CytImmune Sciences Inc.
• 31.10. Nanobiotix
• 31.11. Starpharma Holdings Limited
• 31.12. Copernicus Therapeutics Inc.
• 31.13. NanoCarrier Co. Ltd
• 31.14. LiPlasome Pharma ApS
• 31.15. Nami Therapeutics Corp.

32. Global Healthcare Nanotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Nanotechnology Market

34. Recent Developments In The Healthcare Nanotechnology Market

35. Healthcare Nanotechnology Market High Potential Countries, Segments and Strategies

• 35.1 Healthcare Nanotechnology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Healthcare Nanotechnology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Healthcare Nanotechnology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료